Tamoxifen Therapy Should Last 5 Years.
Tamoxifen has been engulfed in controversy ever since several major studies detected a steep increase in the incidence of uterine cancer among women taking the drug.
Now, a Swedish study of 3887 women indicates that those who took tamoxifen for 5 years had fewer recurrences of breast cancer than women who took the drug for just 2 years. And a U.S. study of 2818 women found that the benefits of 5 years' worth of tamoxifen therapy persisted for 5 years but that there was no additional advantage of a longer course of treatment or any likelihood that a longer course would be worth the accompanying risk of uterine cancer.
-- Science News, 11/23/97
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||breast cancer therapy|
|Date:||Mar 22, 1997|
|Previous Article:||Estrogen and Breast Cancer.|
|Next Article:||Abortion and Breast Cancer.|